Search

Jon K Reel

from Carmel, IN
Age ~70
Get Report
Related to:
Jessica R Thurgood, 41Carrie G Tracy, 55Jennifer N Giles, 46Judy King, 68Albert Guinn
Connected to:
Bryce Reel, 33Chasidy B Reel, 36Christine Reel, 55Dalton E Reel, 31Forest A Reel, 71Jason C Reel, 51Justine J Reel, 83Kaira Reel, 34Kayla R Reel, 33Kent M Reel, 56

Jon Reel Phones & Addresses

  • 14701 Alsong Ct, Carmel, IN 46032 (317) 575-8414
  • Indianapolis, IN
  • Jeff, IN

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Publications

Us Patents

N-(Aryl/Heteroaryl) Amino Acid Esters, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting Alpha- Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6399628, Jun 4, 2002
Filed:
Mar 12, 1999
Appl. No.:
09/266908
Inventors:
James E. Audia - Indianapolis IN
Beverly K. Folmer - Newark DE
Varghese John - San Francisco CA
Lee H. Latimer - Oakland CA
Jeffrey S. Nissen - Indianapolis IN
Jon K. Reel - Carmel IN
Eugene D. Thorsett - Moss Beach CA
Celia A. Whitesitt - Greenwood IN
Assignee:
Athena Neurosciences, Inc. - San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
C07D21538
US Classification:
514311, 514367, 514415, 514423, 514452, 514465, 514467, 514471, 514529, 514533, 514538, 514550, 514567, 546171, 548161, 548496, 548540, 549366, 549439, 549451, 549496, 560 43, 560 45, 560161, 562433, 562457
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Compounds For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis

View page
US Patent:
6476263, Nov 5, 2002
Filed:
Apr 3, 2001
Appl. No.:
09/826412
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Jon K. Reel - Carmel IN
Warren J. Porter - Indianapolis IN
Jeffrey S. Nissen - Indianapolis IN
Thomas E. Mabry - Indianapolis IN
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Beverly K. Folmer - Newark DE
James J. Droste - Indianapolis IN
Thomas C. Britton - Carmel IN
James E. Audia - Indianapolis IN
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
C07C23300
US Classification:
564152, 564153, 564159, 564160, 564161, 564 41, 560 41, 562450
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6541466, Apr 1, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915362
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6544978, Apr 8, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915480
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Bloomington IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6559141, May 6, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915564
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6569851, May 27, 2003
Filed:
Jun 22, 1999
Appl. No.:
09/338191
Inventors:
Richard C. Thompson - Frankfort IN
Stephen Wilkie - Indianapolis IN
Douglas R. Stack - Fishers IN
Eldon E. VanMeter - Greenwood IN
Qing Shi - Carmel IN
Thomas C. Britton - Carmel IN
James E. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Martinsville IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Elan Pharmaceutials, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
C07D24324
US Classification:
514219, 514220, 514221, 540509, 540517, 540518, 540558, 540559, 540560, 540561
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6579867, Jun 17, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915379
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421106, 51421107, 51421204, 51421206, 51421207, 51421208
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds

View page
US Patent:
6632811, Oct 14, 2003
Filed:
Jul 27, 2001
Appl. No.:
09/915342
Inventors:
Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Bloomington IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN
Assignee:
Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
514220, 514221
Abstract:
Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
Control profile
Jon K Reel from Carmel, IN, age ~70 Get Report